Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.2K
Overview
85.2K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

64
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
64
Skin Cancer01:30

Skin Cancer

6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Bone health in women with hidradenitis suppurativa: addressing osteoporosis risks and management options.

International journal of women's dermatology·2026
Same author

MERGE: Misophonia and emotion regulation in a guided experience sampling study.

Hearing research·2026
Same author

Unraveling the strands of inequality: Disparities in low-allergy risk alternatives for High Hair Curl Index Hair.

Journal of the American Academy of Dermatology·2026
Same author

Vitamins and related substances in skin health: Use and restrictions in pregnancy.

Clinics in dermatology·2026
Same author

Dermatology's ether moment: Reflecting on the breakthrough of anesthesia as a lens for recalcitrant pruritus.

Journal of the American Academy of Dermatology·2026
Same author

Hormonal Contraceptives: Part I- Formulations and Physiological Effects on the Skin.

Journal of the American Academy of Dermatology·2026
Same journal

Fertility planning for women in medicine: a call for an active approach.

International journal of women's dermatology·2026
Same journal

Recognizing and managing linear morphea in a pediatric patient with skin of color.

International journal of women's dermatology·2026
Same journal

Common misconceptions of proper sun protection practices among women wearing hijab in Saudi Arabia: a literature review.

International journal of women's dermatology·2026
Same journal

Sequential use of fractional 10600 nm CO<sub>2</sub> and 1540 nm laser for the treatment of labia majora: a minimally invasive synergistic approach to vulval rejuvenation.

International journal of women's dermatology·2026
Same journal

New hair, new rash: is there a correlation?

International journal of women's dermatology·2026
See all related articles

Related Experiment Video

Updated: Mar 2, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

600

A dermatologist guide to immunogenicity.

Collin M Blattner1, Soham P Chaudhari2, John Young3

  • 1Good Samaritan Regional Medical Center, Corvallis, Oregon.

International Journal of Women'S Dermatology
|May 12, 2017
PubMed
Summary
This summary is machine-generated.

Biologic therapy for psoriasis can lead to autoantibody formation, known as immunogenicity, causing loss of drug effectiveness. Low-dose immunomodulators may help prevent these antibodies and maintain treatment efficacy.

Keywords:
HACA antibodiesantidrug antibodiesautoantibodiesbiologic fatigueresistance to biologics

More Related Videos

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.9K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.7K

Related Experiment Videos

Last Updated: Mar 2, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

600
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.9K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.7K

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Biologic therapies are effective for moderate to severe psoriasis.
  • Immunogenicity, or autoantibody formation, can reduce biologic drug efficacy.
  • Biologic fatigue is a related phenomenon impacting treatment outcomes.

Purpose of the Study:

  • To raise dermatologist awareness of immunogenicity and biologic fatigue.
  • To discuss strategies for preventing autoantibody formation during biologic therapy.
  • To provide a treatment algorithm for psoriasis patients experiencing loss of efficacy.

Main Methods:

  • Literature review on immunogenicity and biologic fatigue in psoriasis.
  • Analysis of current data on preventing autoantibody formation.
  • Development of a clinical treatment algorithm.

Main Results:

  • Autoantibody formation is a recognized complication of biologic therapy.
  • Loss of clinical efficacy can result from immunogenicity.
  • Low-dose immunomodulators show potential in preventing autoantibodies.

Conclusions:

  • Dermatologists must consider immunogenicity when managing psoriasis patients on biologics.
  • Preventive strategies, such as immunomodulators, may preserve long-term treatment effectiveness.
  • A structured approach is needed for patients with moderate to severe psoriasis experiencing treatment failure.